Komori
Share Issuance and Disposal4582SymBio Pharmaceuticals LimitedPharmaceuticals

Notice Regarding the Large-Scale Exercise of the 66th Stock Acquisition Rights Issued Through a Third-Party Allotment (with Exercise Price Adjustment Clause)

Between 1 April 2026 and 20 April 2026, 21,700 of the 66th Stock Acquisition Rights were exercised, and 2,170,000 new shares were issued. The number of unexercised stock acquisition rights decreased from 200,000 to 178,300.

Worth reading
69In focus
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
2170000
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Exercise of the 66th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)

発行・処分する株式数

2,170,000 new shares (number of shares issued since the beginning of the month, from 1 April 2026 to 20 April 2026)

Intended allottee
EVO FUND (allottee of the stock acquisition rights)
Terms of the stock acquisition rights
Exercise price
¥114, ¥113, ¥109, ¥106, ¥102, ¥98 and ¥97 (with an exercise price adjustment clause; the lower limit of the adjustment is Not disclosed)
Number of Stock Acquisition Rights
200,000 stock acquisition rights issued in total; 178,300 unexercised as of 20 April 2026 (21,700 exercised during the period)
Most recent equity financing
Timing 12 August 2025 / Type Issuance of the 66th Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed
Details of issuance or disposal
ItemDetails
Type of issuance or disposalExercise of the 66th Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)
Number of shares to be issued or disposed of2,170,000 new shares (number of shares issued since the beginning of the month, from 1 April 2026 to 20 April 2026)
Intended allotteeEVO FUND (allottee of the stock acquisition rights)
Total number of issued shares72,238,910 shares (as of the end of the month preceding the subject month, including 91,169 treasury shares) → Not disclosed
Exercise price¥114, ¥113, ¥109, ¥106, ¥102, ¥98 and ¥97 (with an exercise price adjustment clause; the lower limit of the adjustment is Not disclosed)
Number of Stock Acquisition Rights200,000 stock acquisition rights issued in total; 178,300 unexercised as of 20 April 2026 (21,700 exercised during the period)
Most recent equity financingTiming 12 August 2025 / Type Issuance of the 66th Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company states that the notice concerns the bulk exercise during the period from 1 April 2026 to 20 April 2026, but does not disclose the specific reason for the bulk exercise.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Large-Scale Exercise of the 66th Stock Acquisition Rights Issued Through a Third-Party Allotment (with Exercise Price Adjustment Clause) | SymBio Pharmaceuticals Limited (4582) timely disclosure | Komori